Corrigendum: Differential CCR7 targeting in dendritic cells by three naturally occurring CC-chemokines [Front Immunol., 7, (2016) (568)] doi: 10.3389/fimmu.2016.00568;Differential CCR7 targeting in dendritic cells by three naturally occurring CC-chemokines

Frontiers in Immunology

Volumn 7, Issue DEC, 2016, Pages

  Hjortø, Gertrud M ^a,d   Larsen, Olav ^a   Steen, Anne ^a   Daugvilaite, Viktorija ^a   Berg, Christian ^a   Fares, Suzan ^a   Hansen, Morten ^b   Ali, Simi ^c   Rosenkilde, Mette M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Biased signaling; CCL19; CCL21; CCR7; Dendritic cell; ERK; Tailless CCL21

Indexed keywords

BETA ARRESTIN; BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR7; GLYCOSAMINOGLYCAN; GUANINE NUCLEOTIDE BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL; SECONDARY LYMPHOID TISSUE CHEMOKINE; SIALIC ACID;

ARTICLE; CELL MATURATION; CELL SURFACE; CHEMICAL BINDING; CHEMOTAXIS; CONTROLLED STUDY; DENDRITIC CELL; DNA LIBRARY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOLECULAR DOCKING; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

EID: 85009380346     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00089     Document Type: Erratum

References (71)

1. Viola A, Luster AD. Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol (2008) 48:171-97. doi: 10.1146/annurev.pharmtox.48.121806.154841
2. Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, et al. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem (1997) 272:13803-9. doi:10.1074/jbc.272.21.13803
3. Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, et al. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2014) 66:1-79. doi:10.1124/pr.113.007724
4. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol (2004) 22:891-928. doi:10.1146/annurev.immunol.22.012703.104543
5. Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol (2008) 8:362-71. doi:10.1038/nri2297
6. Ueno T, Saito F, Gray DH, Kuse S, Hieshima K, Nakano H, et al. CCR7 signals are essential for cortex-medulla migration of developing thymocytes. J Exp Med (2004) 200:493-505. doi:10.1084/jem.20040643
7. Misslitz A, Pabst O, Hintzen G, Ohl L, Kremmer E, Petrie HT, et al. Thymic T cell development and progenitor localization depend on CCR7. J Exp Med (2004) 200:481-91. doi:10.1084/jem.20040383
8. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J, et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity (2004) 21:279-88. doi:10.1016/j.immuni.2004.06.014
9. Carlsen HS, Haraldsen G, Brandtzaeg P, Baekkevold ES. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood (2005) 106:444-6. doi:10.1182/blood-2004-11-4353
10. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol (2005) 5:617-28. doi:10.1038/nri1670
11. Gunn MD. Chemokine mediated control of dendritic cell migration and function. Semin Immunol (2003) 15:271-6. doi:10.1016/j.smim.2003.08.004
12. de Paz JL, Moseman EA, Noti C, Polito L, von Andrian UH, Seeberger PH. Profiling heparin-chemokine interactions using synthetic tools. ACS Chem Biol (2007) 2:735-44. doi:10.1021/cb700159m
13. Patel DD, Koopmann W, Imai T, Whichard LP, Yoshie O, Krangel MS. Chemokines have diverse abilities to form solid phase gradients. Clin Immunol (2001) 99:43-52. doi:10.1006/clim.2000.4997
14. Kiermaier E, Moussion C, Veldkamp CT, Gerardy-Schahn R, de Vries I, Williams LG, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science (2016) 351:186-90. doi:10.1126/science.aad0512
15. Schumann K, Lammermann T, Bruckner M, Legler DF, Polleux J, Spatz JP, et al. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity (2010) 32:703-13. doi:10.1016/j.immuni.2010.04.017
16. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science (2005) 308:512-7. doi:10.1126/science.1109237
17. Kenakin T. The potential for selective pharmacological therapies through biased receptor signaling. BMC Pharmacol Toxicol (2012) 13:3. doi:10.1186/2050-6511-13-3
18. Steen A, Larsen O, Thiele S, Rosenkilde MM. Biased and g protein-independent signaling of chemokine receptors. Front Immunol (2014) 5:277. doi:10.3389/fimmu.2014.00277
19. Kohout TA, Nicholas SL, Perry SJ, Reinhart G, Junger S, Struthers RS. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J Biol Chem (2004) 279:23214-22. doi:10.1074/jbc.M402125200
20. Otero C, Groettrup M, Legler DF. Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation. J Immunol (2006) 177:2314-23. doi:10.4049/jimmunol.177.4.2314
21. Zidar DA, Violin JD, Whalen EJ, Lefkowitz RJ. Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands. Proc Natl Acad Sci U S A (2009) 106:9649-54. doi:10.1073/pnas.0904361106
22. Byers MA, Calloway PA, Shannon L, Cunningham HD, Smith S, Li F, et al. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. J Immunol (2008) 181:4723-32. doi:10.4049/jimmunol.181.7.4723
23. Heydorn A, Ward RJ, Jorgensen R, Rosenkilde MM, Frimurer TM, Milligan G, et al. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction. Mol Pharmacol (2004) 66:250-9. doi:10.1124/mol.66.2.250
24. Kostenis E, Zeng FY, Wess J. Functional characterization of a series of mutant G protein alphaq subunits displaying promiscuous receptor coupling properties. J Biol Chem (1998) 273:17886-92. doi:10.1074/jbc.273.28.17886
25. Kissow H, Hartmann B, Holst JJ, Viby NE, Hansen LS, Rosenkilde MM, et al. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice. Regul Pept (2012) 179:91-100. doi:10.1016/j.regpep.2012.08.016
26. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 52:456-67. doi:10.1016/0042-6822(73)90341-3
27. Granas C, Lundholt BK, Heydorn A, Linde V, Pedersen HC, Krog-Jensen C, et al. High content screening for G protein-coupled receptors using cell-based protein translocation assays. Comb Chem High Throughput Screen (2005) 8:301-9. doi:10.2174/1386207054020741
28. Love M, Sandberg JL, Ziarek JJ, Gerarden KP, Rode RR, Jensen DR, et al. Solution structure of CCL21 and identification of a putative CCR7 binding site. Biochemistry (2012) 51:733-5. doi:10.1021/bi201601k
29. Veldkamp CT, Kiermaier E, Gabel-Eissens SJ, Gillitzer ML, Lippner DR, DiSilvio FA, et al. Solution structure of CCL19 and identification of overlapping CCR7 and PSGL-1 binding sites. Biochemistry (2015) 54:4163-6. doi:10.1021/acs.biochem.5b00560
30. Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol (2007) 25:787-820. doi:10.1146/annurev.immunol.24.021605.090529
31. Thiele S, Rosenkilde MM. Interaction of chemokines with their receptors-from initial chemokine binding to receptor activating steps. Curr Med Chem (2014) 21:3594-614. doi:10.2174/0929867321666140716093155
32. Rosenkilde MM, Schwartz TW. GluVII:06-a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors. Curr Top Med Chem (2006) 6:1319-33. doi:10.2174/15680266106061319
33. Schwartz TW. Locating ligand-binding sites in 7TM receptors by protein engineering. Curr Opin Biotechnol (1994) 5:434-44. doi:10.1016/0958-1669(94)90054-X
34. Baldwin JM, Schertler GF, Unger VM. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol (1997) 272:144-64. doi:10.1006/jmbi.1997.1240
35. Ballesteros JA, Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. In: Sealfon SC, editor. Receptor Molecular Biology. New York: Academic Press (1995). p. 366-428.
36. Tan Q, Zhu Y, Li J, Chen Z, Han GW, Kufareva I, et al. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science (2013) 341:1387-90. doi:10.1126/science.1241475
37. Ott TR, Pahuja A, Nickolls SA, Alleva DG, Struthers RS. Identification of CC chemokine receptor 7 residues important for receptor activation. J Biol Chem (2004) 279:42383-92. doi:10.1074/jbc.M401097200
38. Amarandi RM, Hjorto GM, Rosenkilde MM, Karlshoj S. Probing biased signaling in chemokine receptors. Methods Enzymol (2016) 570:155-86. doi:10.1016/bs.mie.2015.09.001
39. McLean KA, Holst PJ, Martini L, Schwartz TW, Rosenkilde MM. Similar activation of signal transduction pathways by the herpesvirus-encoded chemokine receptors US28 and ORF74. Virology (2004) 325:241-51. doi:10.1016/j.virol.2004.04.027
40. Rosenkilde MM, McLean KA, Holst PJ, Schwartz TW. The CXC chemokine receptor encoded by herpesvirus saimiri, ECRF3, shows ligand-regulated signaling through Gi, Gq, and G12/13 proteins but constitutive signaling only through Gi and G12/13 proteins. J Biol Chem (2004) 279:32524-33. doi:10.1074/jbc.M313392200
41. Rosenkilde MM, Schwartz TW. Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptor. Mol Pharmacol (2000) 57:602-9. doi:10.1124/mol.57.3.602
42. Steen A, Sparre-Ulrich AH, Thiele S, Guo D, Frimurer TM, Rosenkilde MM. Gating function of isoleucine-116 in TM-3 (position III:16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5). Br J Pharmacol (2014) 171:1566-79. doi:10.1111/bph.12553
43. Steen A, Thiele S, Guo D, Hansen LS, Frimurer TM, Rosenkilde MM. Biased and constitutive signaling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7. J Biol Chem (2013) 288:12511-21. doi:10.1074/jbc.M112.449587
44. Haessler U, Pisano M, Wu M, Swartz MA. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc Natl Acad Sci U S A (2011) 108:5614-9. doi:10.1073/pnas.1014920108
45. Ricart BG, John B, Lee D, Hunter CA, Hammer DA. Dendritic cells distinguish individual chemokine signals through CCR7 and CXCR4. J Immunol (2011) 186:53-61. doi:10.4049/jimmunol.1002358
46. Kawamura T, Stephens B, Qin L, Yin X, Dores MR, Smith TH, et al. A general method for site specific fluorescent labeling of recombinant chemokines. PLoS One (2014) 9:e81454. doi:10.1371/journal.pone.0081454
47. Weber M, Hauschild R, Schwarz J, Moussion C, de V I, Legler DF, et al. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science (2013) 339:328-32. doi:10.1126/science.1228456
48. Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration. J Cell Sci (2004) 117:4619-28. doi:10.1242/jcs.01481
49. Riol-Blanco L, Sanchez-Sanchez N, Torres A, Tejedor A, Narumiya S, Corbi AL, et al. The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J Immunol (2005) 174:4070-80. doi:10.4049/jimmunol.174.7.4070
50. Scandella E, Men Y, Gillessen S, Forster R, Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood (2002) 100:1354-61. doi:10.1182/blood-2001-11-0017
51. Muthuswamy R, Mueller-Berghaus J, Haberkorn U, Reinhart TA, Schadendorf D, Kalinski P. PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells. Blood (2010) 116:1454-9. doi:10.1182/blood-2009-12-258038
52. Cote SC, Pasvanis S, Bounou S, Dumais N. CCR7-specific migration to CCL19 and CCL21 is induced by PGE(2) stimulation in human monocytes: involvement of EP(2)/EP(4) receptors activation. Mol Immunol (2009) 46:2682-93. doi:10.1016/j.molimm.2008.08.269
53. Aguilera-Montilla N, Chamorro S, Nieto C, Sanchez-Cabo F, Dopazo A, Fernandez-Salguero PM, et al. Aryl hydrocarbon receptor contributes to the MEK/ERK-dependent maintenance of the immature state of human dendritic cells. Blood (2013) 121:e108-17. doi:10.1182/blood-2012-07-445106
54. Li G, Basu S, Han MK, Kim YJ, Broxmeyer HE. Influence of ERK activation on decreased chemotaxis of mature human cord blood monocyte-derived dendritic cells to CCL19 and CXCL12. Blood (2007) 109:3173-6. doi:10.1182/blood-2006-04-014753
55. Vargas P, Maiuri P, Bretou M, Saez PJ, Pierobon P, Maurin M, et al. Innate control of actin nucleation determines two distinct migration behaviours in dendritic cells. Nat Cell Biol (2016) 18:43-53. doi:10.1038/ncb3284
56. Tanizaki H, Egawa G, Inaba K, Honda T, Nakajima S, Moniaga CS, et al. Rho-mDia1 pathway is required for adhesion, migration, and T-cell stimulation in dendritic cells. Blood (2010) 116:5875-84. doi:10.1182/blood-2010-01-264150
57. Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem (1998) 273:7118-22. doi:10.1074/jbc.273.12.7118
58. Hauser MA, Kindinger I, Laufer JM, Spate AK, Bucher D, Vanes SL, et al. Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses. J Leukoc Biol (2016) 99:993-1007. doi:10.1189/jlb.2VMA0915-432RR
59. Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol (2006) 176:5153-9. doi:10.4049/jimmunol.176.9.5153
60. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood (2006) 107:2613-8. doi:10.1182/blood-2005-07-2965
61. Kaiser A, Donnadieu E, Abastado JP, Trautmann A, Nardin A. CC chemokine ligand 19 secreted by mature dendritic cells increases naive T cell scanning behavior and their response to rare cognate antigen. J Immunol (2005) 175:2349-56. doi:10.4049/jimmunol.175.4.2349
62. Hirose J, Kawashima H, Swope WM, Springer TA, Hasegawa H, Yoshie O, et al. Chondroitin sulfate B exerts its inhibitory effect on secondary lymphoid tissue chemokine (SLC) by binding to the C-terminus of SLC. Biochim Biophys Acta (2002) 1571:219-24. doi:10.1016/S0304-4165(02)00232-5
63. Hirose J, Kawashima H, Yoshie O, Tashiro K, Miyasaka M. Versican interacts with chemokines and modulates cellular responses. J Biol Chem (2001) 276:5228-34. doi:10.1074/jbc.M007542200
64. Bruses JL, Rutishauser U. Roles, regulation, and mechanism of polysialic acid function during neural development. Biochimie (2001) 83:635-43. doi:10.1016/S0300-9084(01)01293-7
65. Rey-Gallardo A, Escribano C, Delgado-Martin C, Rodriguez-Fernandez JL, Gerardy-Schahn R, Rutishauser U, et al. Polysialylated neuropilin-2 enhances human dendritic cell migration through the basic C-terminal region of CCL21. Glycobiology (2010) 20:1139-46. doi:10.1093/glycob/cwq078
66. Wegrowski Y, Milard AL, Kotlarz G, Toulmonde E, Maquart FX, Bernard J. Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages. Clin Exp Immunol (2006) 144:485-93. doi:10.1111/j.1365-2249.2006.03059.x
67. Shields JD I, Kourtis C, Tomei AA, Roberts JM, Swartz MA. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science (2010) 328:749-52. doi:10.1126/science.1185837
68. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res (2004) 10:2351-8. doi:10.1158/1078-0432.CCR-03-0195
69. Coghill JM, Carlson MJ, Panoskaltsis-Mortari A, West ML, Burgents JE, Blazar BR, et al. Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells. Blood (2010) 115:4914-22. doi:10.1182/blood-2009-08-239848
70. Kivisakk P, Mahad DJ, Callahan MK, Sikora K, Trebst C, Tucky B, et al. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann Neurol (2004) 55:627-38. doi:10.1002/ana.20049
71. Bielecki B, Jatczak-Pawlik I, Wolinski P, Bednarek A, Glabinski A. Central nervous system and peripheral expression of CCL19, CCL21 and their receptor CCR7 in experimental model of multiple sclerosis. Arch Immunol Ther Exp (Warsz) (2015) 63:367-76. doi:10.1002/ana.20049